Share Name Share Symbol Market Type Share ISIN Share Description
Bellevue Healthcare Trust Plc LSE:BBH London Ordinary Share GB00BZCNLL95 RED ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -2.40 -1.57% 150.60 142,935 13:00:05
Bid Price Offer Price High Price Low Price Open Price
150.20 151.40 150.60 145.40 145.40
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 4.27 1.02 0.07 2,151.4 874
Last Trade Time Trade Type Trade Size Trade Price Currency
12:59:24 O 2,925 150.758 GBX

Bellevue Healthcare (BBH) Latest News (1)

More Bellevue Healthcare News
Bellevue Healthcare Investors    Bellevue Healthcare Takeover Rumours

Bellevue Healthcare (BBH) Discussions and Chat

Bellevue Healthcare Forums and Chat

Date Time Title Posts
09/6/202208:22::: B B HEALTHCARE TRUST :::97
12/7/200616:01Biotech Holders: the last to Run?15

Add a New Thread

Bellevue Healthcare (BBH) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Bellevue Healthcare trades in real-time

Bellevue Healthcare (BBH) Top Chat Posts

Bellevue Healthcare Daily Update: Bellevue Healthcare Trust Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker BBH. The last closing price for Bellevue Healthcare was 153p.
Bellevue Healthcare Trust Plc has a 4 week average price of 132.40p and a 12 week average price of 132.40p.
The 1 year high share price is 209.50p while the 1 year low share price is currently 132.40p.
There are currently 580,037,380 shares in issue and the average daily traded volume is 709,675 shares. The market capitalisation of Bellevue Healthcare Trust Plc is £868,895,995.24.
jonwig: dlp - the asset managers in their monthly factsheets believe the shares are seriously undervalued, and make a good case for that. It's not as though BBH are the only one in the sector suffering! See link in #92.
dlp6666: I'm holding this as a diversified way to gain income in what seemed to be reasonable growth area. Do other holders think BBH will come good, or is it time to ditch? Thanks
xtrmntr:'m not sure if the above link will work.Paul Major, manager of Bellevue Healthcare Trust (BBH), believes the future of healthcare will be very different from what we have today and looks to invest in companies at the forefront of making change possible - from those improving disease diagnosis to companies delivering care at home.  In this podcast, he tells the IC's Mary McDougall where he thinks the most important innovations are developing in healthcare, how he approaches investing in the companies involved and explains the investment case for some of the trust's largest holdings. 
speedsgh: BB Healthcare ups gearing to tap into small stock weakness - HTTPS:// BB Healthcare (BBH) has changed its name but kept faith in smaller healthcare companies after the sector selloff by increasing its borrowing to take advantage of lowly valuations. The £1bn closed-end fund, which has rebranded as Bellevue Healthcare Trust, suffered as the healthcare sector endured its longest selloff since 1994. It had been the darling of the pandemic, but small and medium-sized stocks suffered the worst of the recent downturn in sentiment. Commenting on the investment trust’s recent annual results, fund managers Paul Major and Brett Darke were stoical about the damage the falls have done to their portfolio and said they planned to increase the gearing – or borrowing – in the fund to snap up stock bargains. BBH reported a 10.3% total investment return for the year to 30 November, which lagged the 16.3% rise in the MSCI World Healthcare index, and the defensive sector fell further behind the MSCI World index, which advanced 23.3%. This year has proved difficult. The shares are down 10%; the 12-month return, including dividends, has shrunk by 4.2% due to a ‘violent intra-sector rotation’ in response to high inflation; while rising interest rates, a tech selloff, and war between Russia and Ukraine have darkened the outlook for global economic growth. Major and Darke said they were ‘somewhat lost for a compelling explanation’ as to why healthcare had shouldered such a heavy burden, although the trust’s five-year performance remains credible: a total shareholder return of 83% beats the MSCI World Healthcare return of 70%. ‘Nothing fundamental has changed in the last four weeks, or even four months,’ they said. ‘There are more people alive than before. They are older and they will get sick, with increasingly complex conditions – these are irrefutable truths. Gearing, which stood at 4.9% of net asset value on 30 November, has doubled to 10%, according to data from Numis Securities. ‘If the last two years have taught us anything, it is that everything changes very quickly in such a febrile environment,’ the managers said. Despite the year-to-date fall, the trust has avoided falling to a discount enabling it to issue £18.6m of shares, which combined with the £35.1m increase in borrowings has given them the cash to add to existing holdings and add three new companies ‘one each in tools, diagnostics, and medical technology subsectors’, though they did not disclose the names. ‘One of these is a repurchase of a company that we have owned before but exited on valuation grounds,’ they said. In a post-results briefing this month, Major (above) said the healthcare sector was the best hedge against inflation, citing its strong performance against gold and the consumer prices index over the last 25 years, with the exception of the financial crash in 2008 when gold performed better. Major, who also runs the WS Bellevue Healthcare open-ended fund with Darke, was optimistic about the sector that spends $10tn globally, buoyed by continuous and reliable demand, which will be boosted by ageing populations suffering from chronic pain. ‘While people talk about inflation and stagflation, the data is unarguable: the best hedge you’ve got against inflation is to buy the one thing that nobody wants to consume, but has no choice and will consume: healthcare,’ he said. While the managers are anticipating a bounce-back in healthcare stocks, they said market corrections ‘can go on for much longer than one may realise’, citing the 2000 tech crash as a ‘classic example of prolonged suffering’. ‘We cannot be confident that the mid-cap healthcare rout is close to its denouement, but we can objectively discern value when we see it, and that time is now,’ they said.
speedsgh: Paul Major, portfolio manager of BBH, is presenting on Thurs 17 March at 11am as part of Kepler's Spring Summit entitled Ideas for your ISA. More info & registration here - hxxps://
speedsgh: Results analysis from Kepler Trust Intelligence - HTTPS:// The team behind BB Healthcare Trust (BBH) are bullish on the long term outlook and gearing up after big falls in share prices among healthcare stocks. We spoke to the managers shortly before the trust released its final results for the year ended 30 November 2021, on Monday this week, and they described what they see as a 'fantastic relative opportunity' for investors in the sector after a punishing year. The trust delivered NAV total returns of 10.3% over period, underperforming the MSCI World Healthcare Index total return (GBP) of 16.3%. Share price total returns over the period were slightly higher, at 11.4%. The board has proposed a final dividend of 3.015p per ordinary share in respect of the financial year ended 30 November 2021 and, if approved at the forthcoming AGM, this will bring the total dividend for this year up to 6.03 - ahead of the previous year's. For the year ended 30 November 2022 the board is proposing a total dividend of 6.47p per ordinary share. Kepler View While BB Healthcare has clearly had a difficult and frustrating year, our view is that the trust has been hit by the indiscriminate sell-off in markets we have experienced - especially felt amongst mid and small cap stocks to which BBH is largely exposed. When we met the managers last month they told us it was their view that "history will look back on this moment as a fantastic relative opportunity for long-term healthcare investors", and we note that the team - who have typically used gearing sparingly - have increased the level of gearing to c.10%, underlining their bullishness. BBH offers a complimentary exposure to equity income investors, with an attractive level of dividend derived from capital, and an underlying exposure that is very different from typical income exposures to the healthcare sector… HTTPS://
speedsgh: Change of Name - HTTPS:// The Company confirms that, pursuant to the powers conferred under the Company's Articles of Association, the Board has resolved to change the Company name to Bellevue Healthcare Trust plc with immediate effect. The name change is to ensure consistency between the name of the Company and its Investment Manager, Bellevue Asset Management (UK) Limited. The change of Company name was made by the Registrar of Companies on 1 March 2022. With effect from 8.00 a.m. 2 March 2022, trading will commence under the Company's new name, Bellevue Healthcare Trust plc. The Company's TIDM, ISIN and SEDOL will remain unchanged.
speedsgh: Final Results - HTTPS:// Excerpts from the Chairman's Statement, under header Performance: Though the Company underperformed the Index over the last financial year, I hope that readers will agree that over a five-year period the Investment Manager has delivered attractive returns that compare very favourably to its peer group. The Investment Manager provides more analysis of performance elsewhere in this report; I would highlight that there were periods of the year that the Company was materially ahead of its benchmark. Short-term variations should never change an investment process - and hence it is important to assure investors that the Investment Manager remains true to its investment process and continues to focus on bottom-up fundamental analysis to drive stock selection predicated on superior LONG-TERM returns. Excerpts from the Chairman's Statement, under header Outlook: Continuing on from previous reports, a big driver of market sentiment continues to be the pandemic and in that regard I make no predictions in my outlook. It is clear that this situation has thrown into stark relief that innovation is continuously needed in healthcare and perhaps the rate of that innovation is speeding up. The pandemic has also led to a large backlog of need, thus as we 'normalise' it is likely that there will be a lot of 'pent-up demand'. Your Board continues to believe that your Company is and will continue to be well placed to capitalise on investment opportunities in healthcare to achieve the stated investment objective...
speedsgh: Target total dividend - HTTPS:// As stated in the Company's IPO prospectus and in the Company's prospectus dated 5 November 2018, the Company aims to target a dividend each financial year equal to 3.5 per cent of the Net Asset Value as at the last day of the Company's preceding financial year. The Company intends to pay dividends on a semi-annual basis, by way of two equal dividends, with dividends declared in July and paid in August / September and proposed in February / March and paid in March / April in each year. For the financial year ended 30 November 2021 the Company paid an interim dividend of 3.015p per ordinary share in September 2021 and in due course the Board is intending to propose a final dividend of 3.015p per ordinary share. For the financial year ending 30 November 2022, the target total dividend will be 6.47p per ordinary share, this being 3.5 per cent of the unaudited net asset value per ordinary share of 184.91p per ordinary share (including current financial year revenue items) as at 30 November 2021. The Board intends to declare an interim dividend of 3.235p per ordinary share, being half of the target total dividend for the financial year ending 30 November 2022, in July 2022 and intends to pay this dividend in August / September 2022. The Board intends to propose a final dividend of 3.235p per ordinary share for the financial year ending 30 November 2022, in February / March 2023 and intends to pay this dividend in March / April 2023. Randeep Grewal, Chairman, commented: The Board is pleased to announce that this is the fifth consecutive year of dividend growth for the Company, with an 84.9% increase in distributions over the past five years and a 7.3% increase on last year's level of distribution.
hectorscrackhouse: Yes, Tony, I had emailed the investor relations and repeated the gesture today. Apparently, they do not disclose the portfolio outside of top 10 because of a decision by the independent trust board at launch as a number of institutions replicated the portfolio when holdings were disclosed impacting share prices particularly in small/mid cap names. But they are about to launch an open ended UK OEIC version of BBH and will disclose full portfolio on a semi annual basis.
Bellevue Healthcare share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Bellevue H..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220629 12:18:12